A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]
Pre-publication versions of this article are available by contacting email@example.com.
|9 Apr 2003||Submitted||Original manuscript|
|14 Apr 2003||Reviewed||Reviewer Report - john feehally|
|8 May 2003||Reviewed||Reviewer Report - Joseph Grande|
|19 Jan 2004||Author responded||Author comments - Robert Wyatt|
|Resubmission - Version 2|
|19 Jan 2004||Submitted||Manuscript version 2|
|24 Feb 2004||Reviewed||Reviewer Report - john feehally|
|26 Feb 2004||Reviewed||Reviewer Report - Joseph Grande|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|11 Mar 2004||Author responded||Author comments - Robert Wyatt|
|Resubmission - Version 4|
|11 Mar 2004||Submitted||Manuscript version 4|
|25 Mar 2004||Editorially accepted|
|25 Mar 2004||Article published||10.1186/1471-2369-5-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.